About 13 results found for searched term "60-00-4" (0.036 seconds)
|M1925||LY294002||LY294002 is a highly selective PI3K inhibitor with IC50 values of 0.31, 0.73, 1.06 and 6.60 μM for PI3Kβ, PI3Kα, PI3Kδ and PI3Kγ respectively. LY294002 also inhibits CK2 with an IC50 of 98 nM. LY294002 is a competitive DNA-PK inhibitor that binds reversibly to the kinase domain of DNA-PK with an IC50 of 1.4 μM.|
|M2710||FMK||FMK is a potent and selective inhibitor of p90 ribosomal protein S6 kinaseRSK2 (wt) with IC50 of 15 nM, >600- and 200-fold selectivity for RSK2 than the C436V and T493M mutants.|
|M6589||CGP 60474||CGP60474 is a highly effective anti-endotoxin drug, It is an effective cyclin-dependent kinase (CDK) inhibitor (IC50 of CDK1/B, CDK2/E, CDK2/ A, CDK4/D, CDK5/ P25, CDK7/H and CDK9/T are 26, 3, 4, 216, 10, 200 and 13 nM, respectively). CGP60474 is a selective and ATP-competitive PKC inhibitor.|
|M6699||EDTA||EDTA is a chelating agent. EDTA can activate NOTCH1 signaling.|
|M7399||TC-T 6000||TC-T 6000 is a potent equilibrative nucleoside transporter 4 (ENT4) inhibitor.|
|M7568||AM580||AM580 is a selective RARα agonist with IC50 and EC50 of 8 nM and 0.36 nM, respectively.|
|M8954||Kobe2602||Kobe2602 is analog of Kobe0065, inhibits binding of H-Ras·GTP to c-Raf-1 with a Ki value of 149 ± 55 μM.|
|M9853||Brepocitinib P-Tosylate||PF-06700841 (Brepocitinib) tosylate is a dual inhibitor of JAK1 and TYK2, with IC50 values of 17 nM and 23 nM, respectively.|
|M10510||LY2940094||LY-2940094 is a potent, selective and orally available antagonist of nociceptin receptor (NOP receptor) with Ki of 0.105 nM and Kb of 0.166 nM.|
|M13665||360A iodide||360A iodide is a selective stabilizer of G-quadruplex, and also inhibits telomerase activity with an IC50 of 300 nM for telomerase in TRAP-G4 assay.|
|M13987||CID 16020046||CID 16020046 is a potent and selective GPR55 antagonist and inhibits GPR55 constitutive activity with an IC50 of 0.15 μM.|
|M20808||ML277||ML277 (CID-53347902) is a potent activator of KCNQ1 channels with an EC50 of 260 nM and shows >100-fold selectivity over KCNQ2 and KCNQ4.|
|M21169||PF-60873600||The CDK2/4/6 inhibitor PF-60873600 has oral bioactivity with low Ki values of 0.09 nM, 1.3 nM and 0.16 nM for CDK2, CDK4 and CDK6, respectively.|
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2020 AbMole BioScience. All Rights Reserved.